earnings
confidence high
sentiment negative
materiality 0.65
PetMed Express Q1 net sales $78.2M (+11.5% YoY); net loss $(0.9)M; declares $0.30 dividend
PETMED EXPRESS INC
2024-Q1 EPS reported
-$0.04
revenue$78,244,000
- Net sales $78.2M, up 11.5% YoY from $70.2M; net loss $(0.9)M ($0.04 diluted loss) vs net income $2.8M ($0.14 EPS) in prior year.
- Adjusted EBITDA $3.3M, down 47% from $6.3M; new customers up 25% YoY (third consecutive quarter).
- Board declared quarterly dividend $0.30/share, payable Aug 18, 2023 to holders of record Aug 14, 2023.
- Acquisition of PetCareRx closed Apr 3, 2023; contributed almost full quarter of consolidated results.